North America Human Insulin Market 2020-2026 by Product Type (Drugs, Delivery Devices), Application (Type 1 Diabetes, Type 2 Diabetes, Others), Distribution Channel, and Country: Trend Forecast and Growth Opportunity

Publisher Name :
Date: 18-Jan-2020
No. of pages: 105

North America human insulin market is expected to reach $23.52 billion by 2025, growing by 7.36% annually over the next years.

Highlighted with 27 tables and 52 figures, this 105-page report "North America Human Insulin Market 2020-2026 by Product Type (Drugs, Delivery Devices), Application (Type 1 Diabetes, Type 2 Diabetes, Others), Distribution Channel, and Country: Trend Forecast and Growth Opportunity" is based on a comprehensive research of the entire North America human insulin market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. In this report 2019 is the base year for market analysis, with estimates and forecast covering 2020-2026. (Please Note: The report will be updated before delivery to make sure that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

- Market Structure

- Growth Drivers

- Restraints and Challenges

- Emerging Product Trends & Market Opportunities

- Porter's Fiver Forces

The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view. The balanced (most likely) projection is used to quantify North America human insulin market in every aspect of the classification from perspectives of Product Type, Application, Distribution Channel, and Country.

Based on product type, the North America market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.

- Human Insulin Drugs

- Human Insulin Delivery Devices

Based on product, the North America Human Insulin Drugs market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.

- Modern Human Insulin (further segmented into Long-acting, Rapid- acting, Premixed by type; further segmented into Lantus, Apidra, Levemir, NovoRapid/ NovoLog, Novomix, Humalog, Others by brand)

- Traditional Human Insulin (further segmented into Short-acting, Intermediate & Rapid-acting, Premixed by type; further segmented into Humulin, Insuman, Novolin/Actrapid/Insulatard by brand)

Based on product, the North America Human Insulin Delivery Devices market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.

- Syringes

- Pens (further segmented into Disposable, Reusable, Pen needles)

- Pumps

- Others

Based on application, the North America market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.

- Type 1 Diabetes

- Type 2 Diabetes

- Gestational Diabetes and Prediabetes

Based on distribution channel, the North America market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section.

- Hospital Pharmacies

- Retail Pharmacies

- Online Pharmacies

Geographically, the following national/local markets are fully investigated:

- U.S.

- Canada

For each of the aforementioned countries, market analysis and revenue data are available for 2019-2026. The breakdown of major national markets by Product Type, Application, and Distribution Channel over the study years (2019-2026) is included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in North America human insulin market are assayed quantitatively and qualitatively through GMD's Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players:

Astra Zeneca PLC

Biocon

Eli Lilly

Exir

Julphar

Novo Nordisk AS

Pfizer

Sanofi Aventis

Sedico

Wockhardt

(Please Note: The report will be updated before delivery to make sure that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

North America Human Insulin Market 2020-2026 by Product Type (Drugs, Delivery Devices), Application (Type 1 Diabetes, Type 2 Diabetes, Others), Distribution Channel, and Country: Trend Forecast and Growth Opportunity

Table of Contents
1 Introduction 5
1.1 Industry Definition and Research Scope 5
1.1.1 Industry Definition 5
1.1.2 Research Scope 6
1.2 Research Methodology 8
1.2.1 Overview of Market Research Methodology 8
1.2.2 Market Assumption 9
1.2.3 Secondary Data 9
1.2.4 Primary Data 9
1.2.5 Data Filtration and Model Design 10
1.2.6 Market Size/Share Estimation 11
1.2.7 Research Limitations 12
1.3 Executive Summary 13
2 Market Overview and Dynamics 15
2.1 Market Size and Forecast 15
2.2 Major Growth Drivers 16
2.3 Market Restraints and Challenges 19
2.4 Emerging Opportunities and Market Trends 22
2.5 Porter's Fiver Forces Analysis 25
3 Segmentation of North America Market by Product Type 29
3.1 Market Overview by Product Type 29
3.2 Human Insulin Drugs 31
3.3 Human Insulin Delivery Devices 32
4 Segmentation of North America Human Insulin Drugs Market by Drug Product 33
4.1 Market Overview by Drug Product 33
4.2 Modern Human Insulin 35
4.2.1 Modern Human Insulin by Type 37
4.2.2 Modern Human Insulin by Brand 41
4.3 Traditional Human Insulin 48
4.3.1 Traditional Human Insulin by Type 50
4.3.2 Traditional Human Insulin by Brand 53
5 Segmentation of North America Human Insulin Delivery Devices Market by Device Product 56
5.1 Market Overview by Product 56
5.2 Syringes 58
5.3 Pens 59
5.4 Pumps 60
5.5 Other Devices 62
6 Segmentation of North America Market by Application 63
6.1 Market Overview by Application 63
6.2 Type 1 Diabetes 65
6.3 Type 2 Diabetes 66
6.4 Gestational Diabetes and Prediabetes 67
7 Segmentation of North America Market by Distribution Channel 68
7.1 Market Overview by Distribution Channel 68
7.2 Hospital Pharmacies 70
7.3 Retail Pharmacies 71
7.4 Online Pharmacies 72
8 North America Market 2019-2026 by Country 73
8.1 Overview of North America Market 73
8.2 U.S. Market 76
8.3 Canadian Market 80
9 Competitive Landscape 82
9.1 Overview of Key Vendors 82
9.2 New Product Launch, Partnership, Investment, and M&A 86
9.3 Company Profiles 88
Astra Zeneca PLC 88
Biocon 90
Eli Lilly 91
Exir 92
Julphar 93
Novo Nordisk AS 94
Pfizer 95
Sanofi Aventis 96
Sedico 97
Wockhardt 98
10 Investing in North America Market: Risk Assessment and Management 99
10.1 Risk Evaluation of North America Market 99
10.2 Critical Success Factors (CSFs) 102
Related Reports and Products 105

List of Tables

Table 1. Snapshot of North America Human Insulin Market, 2019-2026 14
Table 2. Main Product Trends and Market Opportunities in North America Human Insulin Market 22
Table 3. North America Human Insulin Market by Product Type, 2019-2026, $ mn 29
Table 4. North America Human Insulin Drugs Market by Product, 2019-2026, $ mn 33
Table 5. North America Human Insulin Drugs Market: Modern Human Insulin by Type, 2019-2026, $ mn 36
Table 6. North America Human Insulin Drugs Market: Modern Human Insulin by Brand, 2019-2026, $ mn 36
Table 7. North America Human Insulin Drugs Market: Traditional Human Insulin by Type, 2019-2026, $ mn 49
Table 8. North America Human Insulin Drugs Market: Traditional Human Insulin by Brand, 2019-2026, $ mn 49
Table 9. North America Human Insulin Delivery Devices Market by Product, 2019-2026, $ mn 56
Table 10. North America Human Insulin Delivery Devices Market: Pens by Product, 2019-2026, $ mn 59
Table 11. North America Human Insulin Market by Application, 2019-2026, $ mn 63
Table 12. North America Human Insulin Market by Distribution Channel, 2019-2026, $ mn 68
Table 13. North America Human Insulin Market by Country, 2019-2026, $ mn 74
Table 14. U.S. Human Insulin Market by Product Type, 2019-2026, $ mn 78
Table 15. U.S. Human Insulin Market by Application, 2019-2026, $ mn 78
Table 16. U.S. Human Insulin Market by Distribution Channel, 2019-2026, $ mn 78
Table 17. Canada Human Insulin Market by Product Type, 2019-2026, $ mn 81
Table 18. Canada Human Insulin Market by Application, 2019-2026, $ mn 81
Table 19. Canada Human Insulin Market by Distribution Channel, 2019-2026, $ mn 81
Table 20. North America Human Insulin Market by Key Vendor, 2019, $ mn 84
Table 21. Astra Zeneca PLC: Company Snapshot 88
Table 22. Astra Zeneca PLC: Business Segmentation 88
Table 23. Astra Zeneca PLC: Product Portfolio 89
Table 24. Astra Zeneca PLC: Revenue, 2016-2018, $ mn 89
Table 25. Astra Zeneca PLC: Recent Developments 89
Table 26. Risk Evaluation for Investing in North America Market, 2019-2026 100
Table 27. Critical Success Factors and Key Takeaways 103

List of Figures

Figure 1. Research Method Flow Chart 8
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 11
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2026 13
Figure 4. North America Human Insulin Market, 2019-2026, $ mn 15
Figure 5. Primary Drivers and Impact Factors of North America Human Insulin Market 16
Figure 6. Primary Restraints and Impact Factors of North America Human Insulin Market 19
Figure 7. Porter's Fiver Forces Analysis of North America Human Insulin Market 25
Figure 8. Breakdown of North America Human Insulin Market by Product Type, 2019-2026, % of Revenue 29
Figure 9. Contribution to North America 2020-2026 Cumulative Revenue by Product Type, Value ($ mn) and Share (%) 30
Figure 10. North America Human Insulin Market: Human Insulin Drugs, 2019-2026, $ mn 31
Figure 11. North America Human Insulin Market: Human Insulin Delivery Devices, 2019-2026, $ mn 32
Figure 12. Breakdown of North America Human Insulin Drugs Market by Product, 2019-2026, % of Revenue 33
Figure 13. Contribution to North America Human Insulin Drugs Cumulative Revenue by Product, 2020-2026, Value ($ mn) and Share (%) 34
Figure 14. North America Human Insulin Market: Modern Human Insulin, 2019-2026, $ mn 35
Figure 15. North America Modern Human Insulin Market: Long-acting, 2019-2026, $ mn 37
Figure 16. North America Modern Human Insulin Market: Rapid- acting, 2019-2026, $ mn 38
Figure 17. North America Modern Human Insulin Market: Premixed, 2019-2026, $ mn 40
Figure 18. North America Modern Human Insulin Market: Lantus, 2019-2026, $ mn 41
Figure 19. North America Modern Human Insulin Market: Apidra, 2019-2026, $ mn 42
Figure 20. North America Modern Human Insulin Market: Levemir, 2019-2026, $ mn 43
Figure 21. North America Modern Human Insulin Market: NovoRapid/ NovoLog, 2019-2026, $ mn 44
Figure 22. North America Modern Human Insulin Market: Novomix, 2019-2026, $ mn 45
Figure 23. North America Modern Human Insulin Market: Humalog, 2019-2026, $ mn 46
Figure 24. North America Modern Human Insulin Market: Other Brands, 2019-2026, $ mn 47
Figure 25. North America Human Insulin Market: Traditional Human Insulin, 2019-2026, $ mn 48
Figure 26. North America Traditional Human Insulin Market: Short-acting, 2019-2026, $ mn 50
Figure 27. North America Traditional Human Insulin Market: Intermediate & Rapid-acting, 2019-2026, $ mn 51
Figure 28. North America Traditional Human Insulin Market: Premixed, 2019-2026, $ mn 52
Figure 29. North America Traditional Human Insulin Market: Humulin, 2019-2026, $ mn 53
Figure 30. North America Traditional Human Insulin Market: Insuman, 2019-2026, $ mn 54
Figure 31. North America Traditional Human Insulin Market: Novolin/Actrapid/Insulatard, 2019-2026, $ mn 55
Figure 32. Breakdown of North America Human Insulin Delivery Devices Market by Product, 2019-2026, % of Revenue 56
Figure 33. Contribution to North America Human Insulin Delivery Devices Cumulative Revenue by Product, 2020-2026, Value ($ mn) and Share (%) 57
Figure 34. North America Human Insulin Delivery Devices Market: Syringes, 2019-2026, $ mn 58
Figure 35. North America Human Insulin Delivery Devices Market: Pens, 2019-2026, $ mn 59
Figure 36. North America Human Insulin Delivery Devices Market: Pumps, 2019-2026, $ mn 60
Figure 37. North America Human Insulin Delivery Devices Market: Other Devices, 2019-2026, $ mn 62
Figure 38. Breakdown of North America Human Insulin Market by Application, 2019-2026, % of Revenue 63
Figure 39. Contribution to North America 2020-2026 Cumulative Revenue by Application, Value ($ mn) and Share (%) 64
Figure 40. North America Human Insulin Market: Type 1 Diabetes, 2019-2026, $ mn 65
Figure 41. North America Human Insulin Market: Type 2 Diabetes, 2019-2026, $ mn 66
Figure 42. North America Human Insulin Market: Gestational Diabetes and Prediabetes, 2019-2026, $ mn 67
Figure 43. Breakdown of North America Human Insulin Market by Distribution Channel, 2019-2026, % of Revenue 68
Figure 44. Contribution to North America 2020-2026 Cumulative Revenue by Distribution Channel, Value ($ mn) and Share (%) 69
Figure 45. North America Human Insulin Market: Hospital Pharmacies, 2019-2026, $ mn 70
Figure 46. North America Human Insulin Market: Retail Pharmacies, 2019-2026, $ mn 71
Figure 47. North America Human Insulin Market: Online Pharmacies, 2019-2026, $ mn 72
Figure 48. Breakdown of North America Human Insulin Market by Country, 2019 and 2026, % of Revenue 74
Figure 49. Contribution to North America 2020-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%) 75
Figure 50. U.S. Human Insulin Market, 2019-2026, $ mn 77
Figure 51. Canada Human Insulin Market, 2019-2026, $ mn 80
Figure 52. Growth Stage of North America Human Insulin Industry over the Forecast Period 82
  • Global and United States Diabetes Drug Market Size, Status and Forecast 2020-2026
    Published: 26-Oct-2020        Price: US 3900 Onwards        Pages: 132
    Global Diabetes Drug Scope and Market Size Diabetes Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Diabetes Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. Market segment by Type, the product can be split into - Insu......
  • (COVID-19 Version) Global Multiple Sclerosis (MS) Drugs Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use
    Published: 24-Oct-2020        Price: US 3000 Onwards        Pages: 139
    Summary The report forecast global Multiple Sclerosis (MS) Drugs market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Multiple Sclerosis (MS) Drugs industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Multiple......
  • (COVID-19 Version) Global Musculoskeletal Disorders Drugs Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use
    Published: 24-Oct-2020        Price: US 3000 Onwards        Pages: 97
    Summary The report forecast global Musculoskeletal Disorders Drugs market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Musculoskeletal Disorders Drugs industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Musc......
  • (COVID-19 Version) Global Metformin Hydrochloride Market Status (2015-2019) and Forecast (2020-2025) by Region, Product Type & End-Use
    Published: 22-Oct-2020        Price: US 3000 Onwards        Pages: 90
    Summary The report forecast global Metformin Hydrochloride market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Metformin Hydrochloride industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Metformin Hydrochlor......
  • Global Antidiabetic Biguanides Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
    Published: 22-Oct-2020        Price: US 3400 Onwards        Pages: 119
    The Antidiabetic Biguanides market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Antidiabetic Biguanides market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Antidiabetic Biguanides market. The report focuses on well-known providers in the global Antidiabetic Biguanides industry, market segments, ......
  • Global Diabetic Therapeutic Drugs Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
    Published: 22-Oct-2020        Price: US 3400 Onwards        Pages: 124
    The Diabetic Therapeutic Drugs market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Diabetic Therapeutic Drugs market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Diabetic Therapeutic Drugs market. The report focuses on well-known providers in the global Diabetic Therapeutic Drugs industry, marke......
  • Global Antidiabetic Thiazolidinediones Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
    Published: 20-Oct-2020        Price: US 3400 Onwards        Pages: 129
    The Antidiabetic Thiazolidinediones market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Antidiabetic Thiazolidinediones market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Antidiabetic Thiazolidinediones market. The report focuses on well-known providers in the global Antidiabetic Thiazolidinedi......
  • Global Liraglutide Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
    Published: 13-Oct-2020        Price: US 3400 Onwards        Pages: 119
    The Liraglutide market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Liraglutide market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Liraglutide market. The report focuses on well-known providers in the global Liraglutide industry, market segments, competition, and the macro environment. ......
  • Global Acarbose Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
    Published: 13-Oct-2020        Price: US 3400 Onwards        Pages: 115
    The Acarbose market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Acarbose market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Acarbose market. The report focuses on well-known providers in the global Acarbose industry, market segments, competition, and the macro environment. Under......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs